Endometriosis is a debilitating disease that still needs surgery to be confirmed. Endometriosis is associated with increased plasma levels of phosphatidylcholines. 
Introduction
Endometriosis is a common gynecological disorder characterized by the presence and growth of endometrial-like tissue, glands and stroma, outside the uterine cavity. It affects up to 10% of women of reproductive age and up to 35% to 50% of women with chronic pelvic pain and/or infertility. 1 The disease can be found in the pelvis, most commonly in the ovaries, pouch of Douglas, and uterosacral ligaments, but other locations such as colon, urinary tract, and lungs have been described. 2, 3 The most frequent symptoms of endometriosis are dysmenorrhea, dyspareunia, chronic pelvic pain, and infertility. 4, 5 The correlation between these symptoms and the stage of endometriosis is poor. 6 In clinical practice, diagnosis of endometriosis is challenging and ultimately requires invasive procedures such as laparoscopy and laparotomy. Clinical evaluation and careful pelvic examination will enable in identifying patients at high risk of endometriosis and select those who need further testing, but making diagnosis only based on symptoms can be misleading. 7, 8 So far, no laboratory tests are helpful in making or confirming a diagnosis of endometriosis. 7, 9 Imaging techniques such as ultrasound and magnetic resonance can reliably locate cystic ovarian lesions and deep infiltrating endometriosis but do not allow the detection of superficial lesions. Therefore, the diagnosis of endometriosis is usually confirmed by laparoscopy, preferably performed in conjunction with histological evaluation of excised lesions. 5, 7, 10 The need of an invasive procedure performed by an experienced surgical team and the reported lack of consistency between laparoscopic and histological diagnosis of endometriosis, in particular for minimal/mild stages, 7, 10, 11 have prompted countless studies in the search of noninvasive diagnostic methods with adequate accuracy. The ideal method should noninvasively detect all types of endometriotic lesions and also provide functional information. However, since the molecular bases of this intriguing clinical condition are poorly understood, over 100 potential biomarkers of endometriosis have been reported, but none has proved to be helpful in clinical practice. 12 In face of the morphological and clinical heterogeneity of endometriosis, gene expression studies and genome-wide association studies (GWAS) have tried to characterize the disorder and provide a comprehensive and noteworthy gene profiling in eutopic and ectopic endometrial tissue of patients with endometriosis. 13, 14 Others have used a metabolomics approach to search for biomarkers of endometriosis. They reported elevated serum levels of sphingomyelins and phosphatidylcholines in women with ovarian endometrioma 15 and in a mouse model of endometriosis. 16 A nuclear medicine technology, positron emission tomography (PET), usually associated with computed tomography (CT), PET/CT, has been widely used as a noninvasive imaging modality for in vivo measurements of biochemical and physiological processes in normal and diseased tissues. 17 Positron emission tomography is a functional diagnostic imaging modality, which is being increasingly used in the field of oncology for detection of several types of cancer, tumor staging and restaging, and therapy response evaluation. 23, 24 Choline is transported into cells and phosphorylated by choline kinase. Then it is metabolized to phosphatidylcholine to be incorporated into the cell membrane. The enzyme choline kinase is overexpressed in a variety of human tumors such as prostate tumor and represents a potential biomarker for diagnostic use. [25] [26] [27] As [ 18 F ]FCH mimics choline transportation and metabolism, increased choline kinase activity in proliferating cells results in high uptake of this radiotracer. 24 \The pathogenesis of endometriosis includes abnormal cell survival and proliferation, chemoattraction of leukocytes, and chronic inflammation. 28 Since all these mechanisms might favor choline uptake, and considering the observation of increased levels of phosphatidylcholines in endometriotic lesions, 29 the aim of this study was to investigate whether 
Materials and Methods

Radiopharmaceutical
The [ 18 Animals were anesthetized with isoflurane (3.5%-4.5% in 100% oxygen). Endometriosis was induced surgically by using the method described by Vernon and colleagues. 31, 32 Basically, 4 fragments of the left uterine horn were excised, opened to expose the endometrium, sutured onto the ventral parietal peritoneum, and horizontally aligned between the inferior renal poles and the bladder, with the serosa facing the peritoneal membrane. In the sham-operated control group, 4 adipose tissue fragments were linearly attached to the peritoneum on the ventral abdominal wall. Around 2 weeks after the initial surgery, the animals were submitted to PET imaging studies and ex vivo biodistribution.
Pathology
Animals were euthanized 12 to 15 days after endometrial/sham implantation and necropsy was performed. Fragments of the endometrial implants and fat implants from sham-operated group were removed, fixed in 10% neutral-buffered formalin, embedded in paraffin, stained with H&E, and examined by bright field microscopy. The histological confirmation of endometriosis induction was based on the morphological identification of endometrial glands and/or stroma in the peritoneal implants.
Biodistribution Assay
The ex vivo biodistribution study of [ 18 F ]FCH was performed 12 to 15 days after endometrial implantation. Rats (n ¼ 12) were fasted for 8 hours followed by intravenous (IV) injection of approximately 5 MBq of [ 18 F ]FCH (lateral tail vein) . Animals were euthanized 30 minutes after injection by cervical dislocation under isoflurane anesthesia (3.5%-4.5% in 100% oxygen). Subsequently, organs/tissues (bladder, ureter, skeletal muscle, ovaries, uterus, kidneys, liver, small intestine, large intestine, 4 endometrial implants, and 4 small fragments of peritoneum) were excised, washed, weighed, and assayed for radioactivity with a gamma counter (Wizard, Model 2480; Perkin Elmer, Wallac, Finland; counting efficiency for photons of 0.511 MeV was 48%). Aliquots containing 1% of the injected dose were counted simultaneously at each time point to calculate radiopharmaceutical uptake which was decay corrected and normalized to the percentage of injected dose per gram of tissue (%ID/g). Mean (SD) uptake was calculated for each organ.
Positron Emission Tomography Imaging
A microPET scanner (LabPET4 Solo; GE Healthcare Technologies, Waukesha, Wisconsin) was used to acquire PET images and to carry out quantitative studies of [ 18 F] FCH distribution and accumulation. The scanner is based on LYSO and LGSO scintillation crystals (2 Â 2 Â 12 mm 3 ), 1536 channels, and sensitivity of 1.1% at energy window of 250 to 650 keV. The intrinsic spatial resolution is around 1 mm Full Width at Half Max at the center of the field of view (FOV) using the maximum likelihood expectation maximization (MLEM) reconstruction method. 33 Transverse and axial FOV are 11.00 and 3.75 cm, respectively.
Endometrial implanted animals and sham-operated controls were used for PET imaging studies. Images were acquired 12 to 15 days after surgery. Before imaging, rats were fasted for 4 to 6 hours with access to water ad libitum. Animals were anesthetized with 3.0% to 4.0% of isoflurane in 100% oxygen before IV injection of [ 18 F]FCH. They were kept warmed and anesthetized during acquisition, in supine position in the scanner, with the long axis of the rat parallel to the long axis of the scanner detectors. Temporal images were acquired 5 minutes after IV administration of 60 MBq/400 mL of [ 18 F] FCH. Three animals of each group, endometrial implanted animals and shamoperated controls, were scanned for 30 minutes using 1 bed position in the region of the surgery.
Images were reconstructed to a 128 Â 128 Â 159 matrix (0.78 Â 0.78 Â 0.80 mm) using a 3D-MLEM iterative reconstruction algorithm with scanner-applied scatter correction. MLEM is expected to produce sharper images with fewer artifacts. The parameters used during each reconstruction were an 80 mm FOV, a span field of 31, and 10 interactions for each step. A normalization file was used for reconstruction process as well as a quantitative calibration file. Nevertheless in the same day, an image of a phantom was acquired and used in order to get a more real factor for calibration purposes, during the quantitative analysis performed in the next step.
Region-of-interest (ROI) analyses of the reconstructed images were performed using PMOD software (version 3.3). Data analysis was performed using ROIs with sizes varying between 1.5 and 3 mm diameter, placed around relevant organs/tissues and around the endometriosis/sham lesions in each case. The ROI analyses of the reconstructed images were performed in order to determine [ 18 F ]FCH uptake which is expressed as %ID/g.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version 5 (Graphpad Software Inc, San Diego, California). Results are expressed as mean (standard deviation) and 95% confidence intervals (CIs). Friedman paired rank test was used to determine the significance of differences in biodistribution and microPET studies. Statistical significance was inferred at P < .05.
Results
Pathology
In the peritoneal cavity of all rats, 3 to 4 endometrial/sham implants were macroscopically identified on autopsy. The endometrial implants were white or yellowish-white, and soft, and the cut surface revealed the presence of fluid-filled, oval-shaped cysts surrounding the sutures ( Figure 1A, B) . The sham implants also were white or yellowish, slightly firm and no cysts were found.
Microscopically, the endometrial implants were characterized by typical endometriotic appearance with endometrial glandular epithelium accompanied by endometrial stroma ( Figure 1C ). The inner lining of the cysts contained simple cubic/columnar epithelium, with endometrial-like glands located at several positions along the interior of the cysts. The stroma was highly vascularized and exhibited discrete to moderate inflammatory infiltrate of lymphocytes and macrophages, a few plasma cells, neutrophils, and eosinophils besides endometrial-like glands ( Figure  1D , E). In addition, inflammatory cells (predominantly neutrophils) were sometimes present within the cyst lumen (Figure 1C) . In sham implants, only adipose and muscle tissues were observed, which were surrounded by discrete fibrosis and inflammatory infiltrate composed predominantly of lymphocytes and macrophages (data not shown).
Biodistribution Study of [18F]FCH
The ex vivo biodistribution study of [ 18 (Figure 2A) . Images showed an increased [ 18 F ]FCH signal at the anatomical site of the implants, contrasting with the abdominal wall and with other neighbor structures ( Figure 3 ). The structures were also observed in 3-dimentional imaging ( Figure 2C ).
The radioactivity concentration within the endometriotic tissue was obtained from the mean value within the multiple ROIs and then converted to %ID/g. The mean (SD) [ 18 F]FCH uptake by ectopic uterine tissue implants was 0.34 (0.04) %ID/g (95% CI 0.24-0.44), whereas the mean (SD) uptake by muscle was 0.08 (0.01) %ID/g (95% CI 0.06-0.10). This difference between lesions and surrounding muscle recapitulates the ex vivo biodistribution results, though the implant uptake/muscle uptake ratio determined by PET imaging was higher (approximately 4).
In order to evaluate the specificity of [ 18 F]FCH-PET in diagnosing endometriosis, sham-operated rats were subjected to a temporal scan for 30 minutes, and the mean uptake value for the sham implanted tissues was 0.26 (0.04) %ID/g (95% CI 0.16-0.36; Figure 2B , D).
Discussion
Biodistribution of [ 18 F ]FCH in animals with endometrial implants was studied 30 minutes postinjection to evaluate tissue accumulation of the radiopharmaceutical . This time interval was chosen considering the high tumor uptake and favorable tumor/muscle ratio, as previously reported in biodistribution studies. 24 In cancer studies, the threshold for tumor/muscle ratio should be at least more than 1. 34 In this study, the endometriotic implants/muscle ratio was approximately 3.0 in the ex vivo assay and 4.0 in the image ROI analysis, indicating high accumulation of the radiotracer and encouraging endometriosis lesion visualization in imaging studies.
In this work, we observed an intense physiological uptake of [ 18 F] FCH by the kidneys. Accordingly, published biodistribution studies using rodents agreed that the kidneys are the primary sites of uptake of [ 18 F] FCH. 26, 27, 35 Also, significant activity was observed in the liver and small intestine. None of these organs interfered with the specificity of the PET imaging, as the kidneys and liver were outside the image frame and the intestines had a more diffuse signal, without any dense points that might be mistaken for the endometriotic implants. The ovaries and the remaining uterine horn also retained [ 18 F] FCH in the ex vivo biodistribution experiment, but these organs did not show any sharp contrast in the abdominal background of the PET images. Uptake of [ 18 F] FCH by the bladder can be a problem to detect lesions in this location. Quite often, however, lesions are not isolated, and the finding of other lesions can point to the need of a laparoscopy or a clinical treatment, which, eventually, would also treat bladder lesions. 36 Using an in vivo model, the current study demonstrated that ectopic endometrial tissue is able to absorb [ 18 24 Previous studies with cultured cells have demonstrated that endometriosis is associated with elevated levels of sphingomyelins and phosphatidylcholines. 15 Positron emission tomography imaging revealed that grafted uterine tissue could be visualized after [ 18 Uchiide et al 37 demonstrated that uterine autotransplantation in rats induces infiltration of allergic inflammatory-related cells in peritoneal stroma attached to the ectopic uterine tissue. In this work, removed tissues were sent for histopathologic examination, confirming endometrial tissue in ventral parietal peritoneum. The histopathological analysis also revealed a discrete to moderate inflammatory infiltrate. The peritoneal microenvironment in the setting of endometriosis induces a chronic, inflammatory reaction characterized by increased amounts of activated macrophages and an associated increase in the levels of inflammatory cytokines, chemokines, growth factors, and prostaglandins. 38 This process may explain the more intense [ 18 F]FCH uptake in the endometriotic implants compared to the remaining uterine horn, which was not labeled in the PET imaging. Local inflammation might also explain [ 18 F ]FCH uptake in fat tissue implants of sham-operated animals.
The gold standard for the diagnosis of endometriosis remains the combination of laparoscopy and the histological verification of endometrial glands and/or stroma. 7 However, this method has limited value as it is dependent on the ability of the surgeon to recognize peritoneal disease, which leads to high false positive rates. Current endoscopic imaging technique limitations have been described as an obstacle for clinical diagnosis. 9 Noninvasive imaging techniques are important for an adequate staging of the disease and therapy approach before surgical interventions. Although case reports of PET imaging using [ 18 F ]FDG have been published, discordant results were observed between conventional imaging and FDG-PET in patients with endometriosis. 21 These preliminary findings of [ 18 F ]FCH uptake by ectopic uterine tissue implants and their localization by microPET imaging encourage the future evaluation of this technique to detect small superficial endometriosis lesions in humans. Future clinical studies with this method should consider the possibility of images produced by other types of inflammatory lesions, which might limit the accuracy of [ 
